Credit Suisse Upgrades Teva Pharma (TEVA) to Outperform; Path to Multiple Steps Forward
Tweet Send to a Friend
(Updated - February 12, 2018 6:19 AM EST)(updated to add analyst comments)Credit Suisse upgraded Teva Pharma (NYSE: TEVA) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
